Calithera Biosciences Inc

NASDAQ:CALA  
1.96
-0.06 (-2.97%)
4:00:13 PM EDT: $1.96 0.00 (0.00%)
Earnings Announcements

Calithera Biosciences Reports Third Quarter 2022 Financial Results

Published: 11/14/2022 21:47 GMT
Calithera Biosciences Inc (CALA) - Calithera Biosciences Reports Third Quarter 2022 Financial Results and Business Update.
Calithera Biosciences Inc - Company Expects It Has Sufficient Cash to Fund Its Operations Into Q2 of 2023.
Calithera Biosciences Inc - Net Loss Was $9.8 Million for Three Months Ended September 30, 2022.
Revenue is expected to be $0 Million
Adjusted EPS is expected to be -$1.68

Next Quarter Revenue Guidance is expected to be $0 Million
Next Quarter EPS Guidance is expected to be -$0.84

More details on our Analysts Page.